Patient Safety Organizations: Voluntary Relinquishment From Peminic Inc. dba The Peminic-Greeley PSO, 71346 [2011-29667]
Download as PDF
<![CDATA[
71346
Federal Register / Vol. 76, No. 222 / Thursday, November 17, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment From
Peminic Inc. dba The Peminic-Greeley
PSO
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Delisting.
AGENCY:
AHRQ has accepted a
notification of voluntary relinquishment
from Peminic Inc. dba The PeminicGreeley PSO of its status as a Patient
Safety Organization (PSO). The Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act), Public Law
109–41, 42 U.S.C. 299b–21—b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR part 3, authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
requirements for listing. A PSO can be
‘‘delisted’’ by the Secretary if it is found
to no longer meet the requirements of
the Patient Safety Act and Patient Safety
Rule, including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
E.T. (2400) on September 13, 2011.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT:
Susan Grinder, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email:
pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
jlentini on DSK4TPTVN1PROD with NOTICES
SUMMARY:
Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
Rule to implement the Patient Safety
VerDate Mar<15>2010
17:25 Nov 16, 2011
Jkt 226001
Act. AHRQ administers the provisions
of the Patient Safety Act and Patient
Safety Rule (PDF file, 450 KB. PDF
Help) relating to the listing and
operation of PSOs. Section 3.108(d) of
the Patient Safety Rule requires AHRQ
to provide public notice when it
removes an organization from the list of
federally approved PSOs. AHRQ has
accepted a notification from Peminic,
Inc. dba The Peminic Greeley PSO, PSO
number P0006, to voluntarily relinquish
its status as a PSO as a result of its
merger with Verge Solutions, LLC.
Accordingly, the Peminic, Inc. dba The
Peminic Greeley PSO was delisted
effective at 12:00 Midnight ET (2400) on
September 13, 2011. A component of
Verge Solutions, LLC sought and
received a new listing as Verge Patient
Safety Organization, P0118, which
became effective on September 14, 2011.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.AHRQ.gov/
index.html.
Dated: October 28, 2011.
Carolyn M. Clancy,
Director.
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–240]
Public Meeting and Request for
Information: Carcinogen and
Recommended Exposure Limit (REL)
Policy Assessment
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting and
request for public comments.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS) announces a public
meeting to review its approach to
classifying carcinogens and establishing
recommended exposure limits (RELs)
for occupational exposures to hazards
associated with cancer. NIOSH
requested initial input on these issues
(including answers to five questions
listed below under SUPPLEMENTARY
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Table of Contents
Date and Time
Place
Status
Security Considerations
Attendee and Speaker Registration
Agenda
For Registration Information Contact
Supplementary Information
I. Background
II. Matters to Be Discussed
III. Transcript
For Further Information Contact
Date and Time: December 12,
2011, 9 a.m.–4 p.m., Eastern Time.
Please note that public comments may
end before the time indicated, following
the last call for comments. Members of
the public who wish to provide public
comments should plan to attend the
meeting at the start time listed.
Place: Hubert H. Humphrey Building,
Room 800, U.S. Department of Health
and Human Services (HHS), 200
Independence Avenue SW.,
Washington, DC 20201.
Status: The meeting is open to the
public, limited only by the space
available. The meeting space
accommodates approximately 135
people. In addition, there will be an
audio conference for those who cannot
attend in person. There is no
registration fee to attend this public
meeting. However, those wishing to
attend are encouraged to sign up by
November 28, 2011 with the contact
person in this notice.
Security Considerations: Due to
mandatory security clearance
procedures at the Hubert H. Humphrey
Federal Building, in-person attendees
must present valid government-issued
picture identification to security
personnel upon entering the building
and go through an airport-type security
check.
Non-U.S. citizens are encouraged to
participate in the audio conferencing
due to the extra clearance involved with
in-person attendance. To attend in
person, a non-U.S. citizen will have to
call or send an email before November
28, 2011, to the contact person in this
DATES:
[FR Doc. 2011–29667 Filed 11–16–11; 8:45 am]
SUMMARY:
INFORMATION), to be submitted to NIOSH
Docket number 240. Written comments
to this Docket will be accepted until
December 30, 2011. Written comments
submitted to the docket will be used to
inform NIOSH with the review and
revision of the carcinogen policy and
the REL policy. NIOSH has also created
a new NIOSH Cancer and REL Policy
Web Topic Page [see https://
www.cdc.gov/niosh/topics/cancer/
policy.html] to provide additional
details about this effort and progress
updates.
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 76, Number 222 (Thursday, November 17, 2011)]
[Notices]
[Page 71346]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-29667]
[[Page 71346]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment From
Peminic Inc. dba The Peminic-Greeley PSO
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of Delisting.
-----------------------------------------------------------------------
SUMMARY: AHRQ has accepted a notification of voluntary relinquishment
from Peminic Inc. dba The Peminic-Greeley PSO of its status as a
Patient Safety Organization (PSO). The Patient Safety and Quality
Improvement Act of 2005 (Patient Safety Act), Public Law 109-41, 42
U.S.C. 299b-21--b-26, provides for the formation of PSOs, which
collect, aggregate, and analyze confidential information regarding the
quality and safety of health care delivery. The Patient Safety and
Quality Improvement Final Rule (Patient Safety Rule), 42 CFR part 3,
authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an
entity that attests that it meets the statutory and regulatory
requirements for listing. A PSO can be ``delisted'' by the Secretary if
it is found to no longer meet the requirements of the Patient Safety
Act and Patient Safety Rule, including when a PSO chooses to
voluntarily relinquish its status as a PSO for any reason.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12:00
Midnight E.T. (2400) on September 13, 2011.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Susan Grinder, Center for Quality
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD
20850; Telephone (toll free): (866) 403-3697; Telephone (local): (301)
427-1111; TTY (toll free): (866) 438-7231; TTY (local): (301) 427-1130;
Email: pso@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
is to conduct activities to improve patient safety and the quality of
health care delivery. HHS issued the Patient Safety Rule to implement
the Patient Safety Act. AHRQ administers the provisions of the Patient
Safety Act and Patient Safety Rule (PDF file, 450 KB. PDF Help)
relating to the listing and operation of PSOs. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of federally approved PSOs. AHRQ
has accepted a notification from Peminic, Inc. dba The Peminic Greeley
PSO, PSO number P0006, to voluntarily relinquish its status as a PSO as
a result of its merger with Verge Solutions, LLC. Accordingly, the
Peminic, Inc. dba The Peminic Greeley PSO was delisted effective at
12:00 Midnight ET (2400) on September 13, 2011. A component of Verge
Solutions, LLC sought and received a new listing as Verge Patient
Safety Organization, P0118, which became effective on September 14,
2011.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.AHRQ.gov/.
Dated: October 28, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011-29667 Filed 11-16-11; 8:45 am]
BILLING CODE 4160-90-M
